How Neural Drive’s Blink-Controlled Brain-Computer Interface Works

The reported interaction is menu-based:

1. The user blinks twice to move through options on a connected laptop or tablet.
2. The user concentrates for several seconds to select an option.
3. The system converts the selection into an action, such as speaking a pre-set phrase, sending a message or operating a connected device.

That design matters because it does not depend entirely on precise hand movement, speech or sustained eye-gaze control. It also keeps the first set of actions relatively constrained, which may make essential communication easier to structure and verify than open-ended thought decoding.

What users can control

Reported examples focus on everyday needs and familiar digital services. Personalised menu options can include:

• requesting food or help;
• selecting phrases such as “I love you”;
• watching television;
• switching lights on or off; and
• making simple choices in the home environment.

The system has also been described as working with external apps and devices through a connected laptop or tablet. Examples include sending simple pre-written WhatsApp messages, watching YouTube videos and controlling smart-home functions.

These are best understood as supported or demonstrated command types, not a guarantee that every user can control every function in WhatsApp, YouTube or a smart-home system. The available reporting describes selected actions and personalised menus rather than unrestricted access to each app.

Why the TTSH clinical trial matters

Tan Tock Seng Hospital (TTSH) announced an 18-month clinical trial beginning in June 2026, involving about 30 patients. The planned participants include stroke survivors with communication and physical difficulties, people with motor neurone disease and people with cerebral palsy.

The trial’s practical question is whether the device can provide communication that is fast and dependable enough for real care settings. That includes people who cannot readily use conventional options such as speech, handwriting, typing, pointing or stable eye contact.

TTSH is also expected to assess whether the technology could fit into speech-therapy work across acute care, rehabilitation and home environments. This is a more meaningful test than early demonstrations alone: a useful assistive device must work consistently for people with different conditions, abilities and caregiving arrangements.

Cost compared with other BCI approaches

The stated hospital price for a Neural Drive unit is about S$2,500. Reported eye-gaze communication systems cost roughly S$10,000 to S$25,000, although suitability varies and some users may struggle to sustain the visual focus or head stability those systems require.

Intracortical BCIs take a fundamentally different approach. They use surgically implanted electrodes to record signals from inside the brain, potentially providing higher-resolution neural data and computer or phone control. The trade-off is the need for surgery, associated medical risks and substantial technical support.

Neural Drive’s proposed advantage is therefore not that it matches an implanted interface in signal resolution. It is that external electrodes could offer a less invasive and potentially more affordable route to a limited set of high-value communication tasks. The TTSH trial will help determine how well that trade-off works in practice.

Who founded Neural Drive—and why

Neural Drive was founded in early 2025 by Khambhati Mohammed Huzefa, Kaushik Manian, Nyan Lin and Raymond Loong Ng. The founders met through hackathons and brought together students and graduates from Singapore’s technology and engineering community.

Huzefa has said that his experience as a Singapore Civil Defence Force medic influenced the company’s direction. He encountered stroke patients who were conscious but unable to tell their families or clinicians whether they were in pain or needed something.

That origin explains the product’s emphasis on short, concrete messages. The goal is not primarily a futuristic demonstration of mind-controlled computing; it is reducing the guesswork involved in meeting a person’s basic needs.

What the early home trials showed—and what they did not

The team reported two-week home trials involving around 60 users to gather feedback. One reported case involved a 67-year-old stroke survivor whose family had previously relied on grunts and inference because he could not form clear words. The device was intended to give him a way to make simple, direct choices instead.

These accounts suggest that the system may have practical value for users and caregivers, but they are early user-feedback observations rather than published evidence of clinical efficacy. The formal TTSH study is the more important test of usability, reliability and clinical value.

What remains unconfirmed

The supplied reporting supports the device’s non-invasive design, its reported hospital-oriented price and the planned TTSH trial. It does not establish that the device has already received hospital or regulatory approval, nor does it confirm a timetable for direct-to-consumer sales.

The available evidence also does not substantiate a firm commitment to donate 1,000 sets. A possible subsidised local-family price of S$500 by late 2026 or early 2027 has been reported, but it should be treated as an expectation rather than a confirmed retail programme.

The larger promise: more direct everyday autonomy

For someone who cannot reliably speak or move, the ability to request help, choose food, send a message or control a light can represent more than convenience. It can create a direct channel for preferences that might otherwise be filtered through a caregiver’s interpretation.

That is the strongest product case for Neural Drive: a relatively simple interface aimed at restoring everyday agency without brain surgery. Whether it can deliver that promise consistently—and for which patients—will depend on the results of clinical testing rather than the technology’s early demonstrations alone.